Cargando…

Mesenchymal Stromal Cells Are More Effective Than Their Extracellular Vesicles at Reducing Lung Injury Regardless of Acute Respiratory Distress Syndrome Etiology

Although mesenchymal stromal cells (MSCs) have demonstrated beneficial effects on experimental acute respiratory distress syndrome (ARDS), preconditioning may be required to potentiate their therapeutic effects. Additionally, administration of cell-free products, such as extracellular vesicles (EVs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Johnatas D., de Castro, Ligia L., Braga, Cassia L., Oliveira, Gisele P., Trivelin, Stefano A., Barbosa-Junior, Carlos M., Morales, Marcelo M., dos Santos, Claudia C., Weiss, Daniel J., Lopes-Pacheco, Miquéias, Cruz, Fernanda F., Rocco, Patricia R. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720722/
https://www.ncbi.nlm.nih.gov/pubmed/31531026
http://dx.doi.org/10.1155/2019/8262849
_version_ 1783448191659671552
author Silva, Johnatas D.
de Castro, Ligia L.
Braga, Cassia L.
Oliveira, Gisele P.
Trivelin, Stefano A.
Barbosa-Junior, Carlos M.
Morales, Marcelo M.
dos Santos, Claudia C.
Weiss, Daniel J.
Lopes-Pacheco, Miquéias
Cruz, Fernanda F.
Rocco, Patricia R. M.
author_facet Silva, Johnatas D.
de Castro, Ligia L.
Braga, Cassia L.
Oliveira, Gisele P.
Trivelin, Stefano A.
Barbosa-Junior, Carlos M.
Morales, Marcelo M.
dos Santos, Claudia C.
Weiss, Daniel J.
Lopes-Pacheco, Miquéias
Cruz, Fernanda F.
Rocco, Patricia R. M.
author_sort Silva, Johnatas D.
collection PubMed
description Although mesenchymal stromal cells (MSCs) have demonstrated beneficial effects on experimental acute respiratory distress syndrome (ARDS), preconditioning may be required to potentiate their therapeutic effects. Additionally, administration of cell-free products, such as extracellular vesicles (EVs) obtained from MSC-conditioned media, might be as effective as MSCs. In this study, we comparatively evaluated the effects of MSCs, preconditioned or not with serum collected from mice with pulmonary or extrapulmonary ARDS (ARDSp and ARDSexp, respectively), and the EVs derived from these cells on lung inflammation and remodeling in ARDSp and ARDSexp mice. Administration of MSCs (preconditioned or not), but not their EVs, reduced static lung elastance, interstitial edema, and collagen fiber content in both ARDSp and ARDSexp. Although MSCs and EVs reduced alveolar collapse and neutrophil cell counts in lung tissue, therapeutic responses were superior in mice receiving MSCs, regardless of preconditioning. Despite higher total cell, macrophage, and neutrophil counts in bronchoalveolar lavage fluid in ARDSp than ARDSexp, MSCs and EVs (preconditioned or not) led to a similar decrease. In ARDSp, both MSCs and EVs, regardless of preconditioning, reduced levels of tumor necrosis factor- (TNF-) α, interleukin-6, keratinocyte chemoattractant (KC), vascular endothelial growth factor (VEGF), and transforming growth factor- (TGF-) β in lung homogenates. In ARDSexp, TNF-α, interleukin-6, and KC levels were reduced by MSCs and EVs, preconditioned or not; only MSCs reduced VEGF levels, while TGF-β levels were similarly increased in ARDSexp treated either with saline, MSCs, or EVs, regardless of preconditioning. In conclusion, MSCs yielded greater overall improvement in ARDS in comparison to EVs derived from the same number of cells and regardless of the preconditioning status. However, the effects of MSCs and EVs differed according to ARDS etiology.
format Online
Article
Text
id pubmed-6720722
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-67207222019-09-17 Mesenchymal Stromal Cells Are More Effective Than Their Extracellular Vesicles at Reducing Lung Injury Regardless of Acute Respiratory Distress Syndrome Etiology Silva, Johnatas D. de Castro, Ligia L. Braga, Cassia L. Oliveira, Gisele P. Trivelin, Stefano A. Barbosa-Junior, Carlos M. Morales, Marcelo M. dos Santos, Claudia C. Weiss, Daniel J. Lopes-Pacheco, Miquéias Cruz, Fernanda F. Rocco, Patricia R. M. Stem Cells Int Research Article Although mesenchymal stromal cells (MSCs) have demonstrated beneficial effects on experimental acute respiratory distress syndrome (ARDS), preconditioning may be required to potentiate their therapeutic effects. Additionally, administration of cell-free products, such as extracellular vesicles (EVs) obtained from MSC-conditioned media, might be as effective as MSCs. In this study, we comparatively evaluated the effects of MSCs, preconditioned or not with serum collected from mice with pulmonary or extrapulmonary ARDS (ARDSp and ARDSexp, respectively), and the EVs derived from these cells on lung inflammation and remodeling in ARDSp and ARDSexp mice. Administration of MSCs (preconditioned or not), but not their EVs, reduced static lung elastance, interstitial edema, and collagen fiber content in both ARDSp and ARDSexp. Although MSCs and EVs reduced alveolar collapse and neutrophil cell counts in lung tissue, therapeutic responses were superior in mice receiving MSCs, regardless of preconditioning. Despite higher total cell, macrophage, and neutrophil counts in bronchoalveolar lavage fluid in ARDSp than ARDSexp, MSCs and EVs (preconditioned or not) led to a similar decrease. In ARDSp, both MSCs and EVs, regardless of preconditioning, reduced levels of tumor necrosis factor- (TNF-) α, interleukin-6, keratinocyte chemoattractant (KC), vascular endothelial growth factor (VEGF), and transforming growth factor- (TGF-) β in lung homogenates. In ARDSexp, TNF-α, interleukin-6, and KC levels were reduced by MSCs and EVs, preconditioned or not; only MSCs reduced VEGF levels, while TGF-β levels were similarly increased in ARDSexp treated either with saline, MSCs, or EVs, regardless of preconditioning. In conclusion, MSCs yielded greater overall improvement in ARDS in comparison to EVs derived from the same number of cells and regardless of the preconditioning status. However, the effects of MSCs and EVs differed according to ARDS etiology. Hindawi 2019-08-21 /pmc/articles/PMC6720722/ /pubmed/31531026 http://dx.doi.org/10.1155/2019/8262849 Text en Copyright © 2019 Johnatas D. Silva et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Silva, Johnatas D.
de Castro, Ligia L.
Braga, Cassia L.
Oliveira, Gisele P.
Trivelin, Stefano A.
Barbosa-Junior, Carlos M.
Morales, Marcelo M.
dos Santos, Claudia C.
Weiss, Daniel J.
Lopes-Pacheco, Miquéias
Cruz, Fernanda F.
Rocco, Patricia R. M.
Mesenchymal Stromal Cells Are More Effective Than Their Extracellular Vesicles at Reducing Lung Injury Regardless of Acute Respiratory Distress Syndrome Etiology
title Mesenchymal Stromal Cells Are More Effective Than Their Extracellular Vesicles at Reducing Lung Injury Regardless of Acute Respiratory Distress Syndrome Etiology
title_full Mesenchymal Stromal Cells Are More Effective Than Their Extracellular Vesicles at Reducing Lung Injury Regardless of Acute Respiratory Distress Syndrome Etiology
title_fullStr Mesenchymal Stromal Cells Are More Effective Than Their Extracellular Vesicles at Reducing Lung Injury Regardless of Acute Respiratory Distress Syndrome Etiology
title_full_unstemmed Mesenchymal Stromal Cells Are More Effective Than Their Extracellular Vesicles at Reducing Lung Injury Regardless of Acute Respiratory Distress Syndrome Etiology
title_short Mesenchymal Stromal Cells Are More Effective Than Their Extracellular Vesicles at Reducing Lung Injury Regardless of Acute Respiratory Distress Syndrome Etiology
title_sort mesenchymal stromal cells are more effective than their extracellular vesicles at reducing lung injury regardless of acute respiratory distress syndrome etiology
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720722/
https://www.ncbi.nlm.nih.gov/pubmed/31531026
http://dx.doi.org/10.1155/2019/8262849
work_keys_str_mv AT silvajohnatasd mesenchymalstromalcellsaremoreeffectivethantheirextracellularvesiclesatreducinglunginjuryregardlessofacuterespiratorydistresssyndromeetiology
AT decastroligial mesenchymalstromalcellsaremoreeffectivethantheirextracellularvesiclesatreducinglunginjuryregardlessofacuterespiratorydistresssyndromeetiology
AT bragacassial mesenchymalstromalcellsaremoreeffectivethantheirextracellularvesiclesatreducinglunginjuryregardlessofacuterespiratorydistresssyndromeetiology
AT oliveiragiselep mesenchymalstromalcellsaremoreeffectivethantheirextracellularvesiclesatreducinglunginjuryregardlessofacuterespiratorydistresssyndromeetiology
AT trivelinstefanoa mesenchymalstromalcellsaremoreeffectivethantheirextracellularvesiclesatreducinglunginjuryregardlessofacuterespiratorydistresssyndromeetiology
AT barbosajuniorcarlosm mesenchymalstromalcellsaremoreeffectivethantheirextracellularvesiclesatreducinglunginjuryregardlessofacuterespiratorydistresssyndromeetiology
AT moralesmarcelom mesenchymalstromalcellsaremoreeffectivethantheirextracellularvesiclesatreducinglunginjuryregardlessofacuterespiratorydistresssyndromeetiology
AT dossantosclaudiac mesenchymalstromalcellsaremoreeffectivethantheirextracellularvesiclesatreducinglunginjuryregardlessofacuterespiratorydistresssyndromeetiology
AT weissdanielj mesenchymalstromalcellsaremoreeffectivethantheirextracellularvesiclesatreducinglunginjuryregardlessofacuterespiratorydistresssyndromeetiology
AT lopespachecomiqueias mesenchymalstromalcellsaremoreeffectivethantheirextracellularvesiclesatreducinglunginjuryregardlessofacuterespiratorydistresssyndromeetiology
AT cruzfernandaf mesenchymalstromalcellsaremoreeffectivethantheirextracellularvesiclesatreducinglunginjuryregardlessofacuterespiratorydistresssyndromeetiology
AT roccopatriciarm mesenchymalstromalcellsaremoreeffectivethantheirextracellularvesiclesatreducinglunginjuryregardlessofacuterespiratorydistresssyndromeetiology